德国甲状腺结节功能状态分布及功能亢进和功能低下甲状腺结节恶性肿瘤发生率。

IF 1 4区 医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Simone Agnes Schenke, Michael C Kreissl, Michael Grunert, Anja Hach, Sarvar Haghghi, Tatjana Kandror, Eckhard Peppert, Sandra Rosenbaum-Krumme, Verena Ruhlmann, Alexander Stahl, Dieter Wanjura, Konstantin Zaplatnikov, Michael Zimny, Elena Gilman, Ken Herrmann, Rainer Görges
{"title":"德国甲状腺结节功能状态分布及功能亢进和功能低下甲状腺结节恶性肿瘤发生率。","authors":"Simone Agnes Schenke,&nbsp;Michael C Kreissl,&nbsp;Michael Grunert,&nbsp;Anja Hach,&nbsp;Sarvar Haghghi,&nbsp;Tatjana Kandror,&nbsp;Eckhard Peppert,&nbsp;Sandra Rosenbaum-Krumme,&nbsp;Verena Ruhlmann,&nbsp;Alexander Stahl,&nbsp;Dieter Wanjura,&nbsp;Konstantin Zaplatnikov,&nbsp;Michael Zimny,&nbsp;Elena Gilman,&nbsp;Ken Herrmann,&nbsp;Rainer Görges","doi":"10.1055/a-1856-4052","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Thyroid scintigraphy enables the depiction of the functional status of thyroid nodules (TNs) with both, <sup>99m</sup>Tc-pertechnetate and <sup>123</sup>Iodine. The functional status is relevant for diagnostic procedures for the differentiation of benign and malignant TNs. The aim of this study was to examine the current frequencies of hyper-, hypo- and isofunctioning TNs in Germany and to estimate the risk of malignancy with regard to functional status.</p><p><strong>Methods: </strong>In 11 study centers, a minimum of 100 nodules per center were consecutively enrolled between July 2019 and April 2020. Inclusion criteria were: newly diagnosed nodule, nodule' size of 10 mm or more, thyroid scintigraphy. Exclusion criteria were: completely cystic TNs, patients with prior radioiodine therapy or thyroid surgery. The risk of malignancy was estimated for hyper- and hypofunctioning TNs.</p><p><strong>Results: </strong>Overall, 849 patients (72 % women) with 1262 TNs were included. Patients' age ranged from 18 to 90 years. Most TNs were hypofunctioning (n=535, 42%) followed by isofunctioning TNs (n=488, 39%) and hyperfunctioning TNs (n=239, 19%). When only TNs with a maximum size of 2 cm or more were considered the rate of hyperfunctioning and hypofunctioning TNs increased (to 27% and 49%) while isofunctioning TNs decreased. Only one of all hyperfunctioning TNs was malignant. In hypofunctioning nodules, the malignancy rate was estimated at 10%.</p><p><strong>Conclusion: </strong>In Germany, the proportion of hyperfunctioning TNs is approximately 20% and increases in larger TNs to up to 27%. Due to the low risk of malignancy in hyperfunctioning TNs, no further procedures to rule out malignancy are necessary. The risk of malignancy of hypofunctioning TNs is significantly higher. Thus, a thyroid scintigraphy is a useful diagnostic tool in Germany.</p>","PeriodicalId":19238,"journal":{"name":"Nuklearmedizin-nuclear Medicine","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany.\",\"authors\":\"Simone Agnes Schenke,&nbsp;Michael C Kreissl,&nbsp;Michael Grunert,&nbsp;Anja Hach,&nbsp;Sarvar Haghghi,&nbsp;Tatjana Kandror,&nbsp;Eckhard Peppert,&nbsp;Sandra Rosenbaum-Krumme,&nbsp;Verena Ruhlmann,&nbsp;Alexander Stahl,&nbsp;Dieter Wanjura,&nbsp;Konstantin Zaplatnikov,&nbsp;Michael Zimny,&nbsp;Elena Gilman,&nbsp;Ken Herrmann,&nbsp;Rainer Görges\",\"doi\":\"10.1055/a-1856-4052\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>Thyroid scintigraphy enables the depiction of the functional status of thyroid nodules (TNs) with both, <sup>99m</sup>Tc-pertechnetate and <sup>123</sup>Iodine. The functional status is relevant for diagnostic procedures for the differentiation of benign and malignant TNs. The aim of this study was to examine the current frequencies of hyper-, hypo- and isofunctioning TNs in Germany and to estimate the risk of malignancy with regard to functional status.</p><p><strong>Methods: </strong>In 11 study centers, a minimum of 100 nodules per center were consecutively enrolled between July 2019 and April 2020. Inclusion criteria were: newly diagnosed nodule, nodule' size of 10 mm or more, thyroid scintigraphy. Exclusion criteria were: completely cystic TNs, patients with prior radioiodine therapy or thyroid surgery. The risk of malignancy was estimated for hyper- and hypofunctioning TNs.</p><p><strong>Results: </strong>Overall, 849 patients (72 % women) with 1262 TNs were included. Patients' age ranged from 18 to 90 years. Most TNs were hypofunctioning (n=535, 42%) followed by isofunctioning TNs (n=488, 39%) and hyperfunctioning TNs (n=239, 19%). When only TNs with a maximum size of 2 cm or more were considered the rate of hyperfunctioning and hypofunctioning TNs increased (to 27% and 49%) while isofunctioning TNs decreased. Only one of all hyperfunctioning TNs was malignant. In hypofunctioning nodules, the malignancy rate was estimated at 10%.</p><p><strong>Conclusion: </strong>In Germany, the proportion of hyperfunctioning TNs is approximately 20% and increases in larger TNs to up to 27%. Due to the low risk of malignancy in hyperfunctioning TNs, no further procedures to rule out malignancy are necessary. The risk of malignancy of hypofunctioning TNs is significantly higher. Thus, a thyroid scintigraphy is a useful diagnostic tool in Germany.</p>\",\"PeriodicalId\":19238,\"journal\":{\"name\":\"Nuklearmedizin-nuclear Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2022-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nuklearmedizin-nuclear Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-1856-4052\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuklearmedizin-nuclear Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-1856-4052","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 5

摘要

目的:甲状腺显像能够描述甲状腺结节(TNs)的功能状态,99mtc -高锝酸盐和123碘。功能状态与鉴别良性和恶性TNs的诊断程序有关。本研究的目的是检查德国高功能、低功能和等功能TNs的当前频率,并估计与功能状态相关的恶性肿瘤风险。方法:在2019年7月至2020年4月期间,在11个研究中心中,每个中心至少连续入组100个结节。纳入标准:新诊断结节,结节大小≥10mm,甲状腺显像。排除标准为:完全囊性TNs,既往放射性碘治疗或甲状腺手术患者。对功能亢进和功能低下的TNs进行恶性肿瘤的风险评估。结果:共纳入849例患者(72%为女性),共1262例TNs。患者年龄从18岁到90岁不等。大多数TNs为功能低下(n=535, 42%),其次为功能等(n=488, 39%)和功能亢进(n=239, 19%)。当仅考虑最大尺寸为2 cm或更大的TNs时,功能亢进和功能低下的TNs的比例增加(分别为27%和49%),而功能正常的TNs则减少。所有功能亢进的tn中只有一个是恶性的。在功能低下的结节中,恶性率估计为10%。结论:在德国,功能亢进的TNs比例约为20%,较大的TNs增加至27%。由于功能亢进的TNs发生恶性肿瘤的风险较低,因此不需要进一步的手术来排除恶性肿瘤。功能不全的TNs发生恶性肿瘤的风险明显更高。因此,甲状腺显像在德国是一种有用的诊断工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany.

Aim: Thyroid scintigraphy enables the depiction of the functional status of thyroid nodules (TNs) with both, 99mTc-pertechnetate and 123Iodine. The functional status is relevant for diagnostic procedures for the differentiation of benign and malignant TNs. The aim of this study was to examine the current frequencies of hyper-, hypo- and isofunctioning TNs in Germany and to estimate the risk of malignancy with regard to functional status.

Methods: In 11 study centers, a minimum of 100 nodules per center were consecutively enrolled between July 2019 and April 2020. Inclusion criteria were: newly diagnosed nodule, nodule' size of 10 mm or more, thyroid scintigraphy. Exclusion criteria were: completely cystic TNs, patients with prior radioiodine therapy or thyroid surgery. The risk of malignancy was estimated for hyper- and hypofunctioning TNs.

Results: Overall, 849 patients (72 % women) with 1262 TNs were included. Patients' age ranged from 18 to 90 years. Most TNs were hypofunctioning (n=535, 42%) followed by isofunctioning TNs (n=488, 39%) and hyperfunctioning TNs (n=239, 19%). When only TNs with a maximum size of 2 cm or more were considered the rate of hyperfunctioning and hypofunctioning TNs increased (to 27% and 49%) while isofunctioning TNs decreased. Only one of all hyperfunctioning TNs was malignant. In hypofunctioning nodules, the malignancy rate was estimated at 10%.

Conclusion: In Germany, the proportion of hyperfunctioning TNs is approximately 20% and increases in larger TNs to up to 27%. Due to the low risk of malignancy in hyperfunctioning TNs, no further procedures to rule out malignancy are necessary. The risk of malignancy of hypofunctioning TNs is significantly higher. Thus, a thyroid scintigraphy is a useful diagnostic tool in Germany.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.70
自引率
13.30%
发文量
267
审稿时长
>12 weeks
期刊介绍: Als Standes- und Fachorgan (Organ von Deutscher Gesellschaft für Nuklearmedizin (DGN), Österreichischer Gesellschaft für Nuklearmedizin und Molekulare Bildgebung (ÖGN), Schweizerischer Gesellschaft für Nuklearmedizin (SGNM, SSNM)) von hohem wissenschaftlichen Anspruch befasst sich die CME-zertifizierte Nuklearmedizin/ NuclearMedicine mit Diagnostik und Therapie in der Nuklearmedizin und dem Strahlenschutz: Originalien, Übersichtsarbeiten, Referate und Kongressberichte stellen aktuelle Themen der Diagnose und Therapie dar. Ausführliche Berichte aus den DGN-Arbeitskreisen, Nachrichten aus Forschung und Industrie sowie Beschreibungen innovativer technischer Geräte, Einrichtungen und Systeme runden das Konzept ab. Die Abstracts der Jahrestagungen dreier europäischer Fachgesellschaften sind Bestandteil der Kongressausgaben. Nuklearmedizin erscheint regelmäßig mit sechs Ausgaben pro Jahr und richtet sich vor allem an Nuklearmediziner, Radiologen, Strahlentherapeuten, Medizinphysiker und Radiopharmazeuten.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信